These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25017110)

  • 1. Iron uptake and ferrokinetics in healthy male subjects of an iron-based oral phosphate binder (SBR759) labeled with the stable isotope (58)Fe.
    Gschwind HP; Schmid DG; von Blanckenburg F; Oelze M; van Zuilen K; Slade AJ; Stitah S; Kaufmann D; Swart P
    Metallomics; 2014 Nov; 6(11):2062-71. PubMed ID: 25017110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of SBR759, a new iron-based phosphate binder.
    Block GA; Brillhart SL; Persky MS; Amer A; Slade AJ
    Kidney Int; 2010 May; 77(10):897-903. PubMed ID: 20375984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
    Chen JB; Chiang SS; Chen HC; Obayashi S; Nagasawa M; Hexham JM; Balfour A; Junge G; Akiba T; Fukagawa M
    Nephrology (Carlton); 2011 Nov; 16(8):743-50. PubMed ID: 21854503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy.
    Fukagawa M; Kasuga H; Joseph D; Sawata H; Junge G; Moore A; Akiba T
    Clin Exp Nephrol; 2014 Feb; 18(1):135-43. PubMed ID: 23670305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An iron stable isotope comparison between human erythrocytes and plasma.
    von Blanckenburg F; Oelze M; Schmid DG; van Zuilen K; Gschwind HP; Slade AJ; Stitah S; Kaufmann D; Swart P
    Metallomics; 2014 Nov; 6(11):2052-61. PubMed ID: 25017012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of the enriched stable isotope
    Yagob T; van de Wiel A; Bode P; Demir A; van der Wagt B; Krystek P; Wolterbeek B
    J Trace Elem Med Biol; 2019 May; 53():77-83. PubMed ID: 30910211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the iron isotopic composition of human whole blood and iron status parameters.
    Van Heghe L; Delanghe J; Van Vlierberghe H; Vanhaecke F
    Metallomics; 2013 Nov; 5(11):1503-9. PubMed ID: 23903806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials.
    Zhu Y; Rao J; Liao X; Ou J; Li W; Xue C
    Int Urol Nephrol; 2021 Sep; 53(9):1899-1909. PubMed ID: 33675476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate.
    Vaziri ND; Nunes ACF; Said H; Khazaeli M; Liu H; Zhao Y; Jing W; Cogburn K; Alikhani L; Lau WL
    Nephrol Dial Transplant; 2020 Jul; 35(7):1136-1144. PubMed ID: 32514572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron absorption by human subjects from different iron fortification compounds added to Thai fish sauce.
    Walczyk T; Tuntipopipat S; Zeder C; Sirichakwal P; Wasantwisut E; Hurrell RF
    Eur J Clin Nutr; 2005 May; 59(5):668-74. PubMed ID: 15756294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcium on iron absorption in women with marginal iron status.
    Benkhedda K; L'abbé MR; Cockell KA
    Br J Nutr; 2010 Mar; 103(5):742-8. PubMed ID: 19860985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotope ratio measurements of iron in blood samples by multi-collector ICP-MS to support nutritional investigations in humans.
    Benkhedda K; Chen H; Dabeka R; Cockell K
    Biol Trace Elem Res; 2008 May; 122(2):179-92. PubMed ID: 18188515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
    Schümann K; Kroll S; Romero-Abal ME; Georgiou NA; Marx JJ; Weiss G; Solomons NW
    Ann Nutr Metab; 2012; 60(2):98-107. PubMed ID: 22398912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of the new oral phosphate binder Lenziaren(®) in healthy cats fed a renal diet.
    King JN; Delport PC; Luus HG; Erasmus HL; Barnes PM; Speranza C
    J Vet Pharmacol Ther; 2015 Jun; 38(3):278-89. PubMed ID: 25363785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
    Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB
    Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.